Browsing Barts Cancer Institute by Title
Now showing items 1147-1165 of 1165
-
Variations in gynecologic oncology training in low (LIC) and middle income (MIC) countries (LMICs): Common efforts and challenges.
(2017-05)Gynecologic cancer, cervical cancer in particular, is disproportionately represented in the developing world where mortality is also high. Screening programs, increased availability of chemotherapy, and an awareness of ... -
Venetoclax-based low intensity therapy in molecular failure of NPM1 mutated AML.
(2023-12-01)Molecular failure in NPM1 mutated AML inevitably progresses to frank relapse if untreated. Recently published small case series show that venetoclax combined with low dose cytarabine or azacitidine can reduce or eliminate ... -
Volatile organic compounds (VOCs) for the non-invasive detection of pancreatic cancer from urine.
(2021-01-01)Pancreatic ductal adenocarcinoma (PDAC) is a particularly challenging cancer, with very low 5-year survival rates. This low survival rate is linked to late stage diagnosis, associated with the lack of approved biomarkers. ...